A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
The biology of immunoglobulin free light chains and kidney injury - Kidney International
Is accuracy of serum free light chain measurement achievable?
A new free light chain immunoassay shows advantages in the classification and in the follow-up of patients with paraproteinemia compared to a nephelometric assay
Manni Mohyuddin on Twitter: "Well- Normally kappa FLC are produced more often than lambda.. BUT lambda more frequently forms dimers, which doubles their molecular weight and slows their renal clearance..." / Twitter
Serum free light chain assessment in monoclonal gammopathy and kidney disease | Nature Reviews Nephrology
free light chains ratio in AL amyloidosis, kappa and lambdaAmyloidosis Patient Information Site
FREE LIGHT CHAINS (SERUM) | REGIONAL MEDICAL LABORATORY
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Frontiers | Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency?
Serum free light chain ratio predicts outcome in MGUS | Semantic Scholar
FREE LIGHT CHAINS (SERUM) | REGIONAL MEDICAL LABORATORY
Serum Free Light Chains
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia